探索三阴性乳腺癌化学免疫治疗中的"化疗"
1Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA.
Cancer cell
|March 11, 2025
概括
这项研究比较了用阿特佐利祖马布加化疗治疗的三阴性乳腺癌的免疫细胞. 纳布-帕克利塔塞尔组合显示出独特的T细胞激活和巨细胞在免疫反应中的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择的侵袭性亚型.
- 像PD-L1抑制剂这样的免疫检查点抑制剂在TNBC治疗中表现有前途.
- 了解免疫细胞动态对于优化组合疗法至关重要.
研究的目的:
- 为了比较TNBC患者的免疫细胞反应,他们接受了阿特佐利祖马布加帕克利塔塞尔治疗,而不是纳布-帕克利塔塞尔.
- 为了确定由不同的化疗骨干诱导的特定免疫细胞激活模式.
- 阐明巨细胞在免疫疗法反应中的作用.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 用于分析免疫细胞群.
- 进行了对T细胞激活标记物和免疫细胞透的比较分析.
- 在TNBC患者的瘤微环境中评估了免疫细胞动态.
主要成果:
- 在两个治疗手臂之间观察到明显的T细胞激活模式.
- 巨细胞在免疫激活中发挥了显著作用,仅在nab-paclitaxel组合组中.
- scRNA-seq确定了与治疗反应相关的特定免疫细胞特征.
结论:
- 选择化疗骨干显著影响免疫细胞动态与PD-L1抑制剂结合使用.
- 纳布-帕克利塔塞尔与阿特佐利祖马布结合,促进了独特的免疫激活特征,可能涉及巨细胞.
- 这些发现可能有助于开发更有效的TNBC组合免疫疗法.
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.5K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
